In this large proteomic dataset, differences in BH3-mimetic and BCL-2 protein expression were found in FAB and cytogenetic subgroups, supporting a preferential usage of different molecules within the intrinsic apoptotic pathway in subsets of AML (178). The gene discussed is BCL2; the disease is acute myeloid leukemia.